Spain Stefanie Granado, director general of Takeda Iberia recounts the opportunities available for Takeda in Spain following its acquisition of Shire. She also discusses Takeda’s local acquisition of TiGenix, handing Takeda stem cell production capabilities, and how this makes Spain a key market and hub for the company. We continue…
Sweden Malin Parkler, country manager of Pfizer Sweden, breaks down the extensive footprint of Pfizer in Sweden across the value chain, lays down the advantages of Sweden as a research and manufacturing hub, and shares the exciting local collaborations and partnerships the company is developing to support healthcare and patients. …
Sweden Andrea Sambatti is the general manager of Boehringer Ingelheim (BI) Sweden and is a member of the board of directors for LIF. Sambatti discusses how Sweden is a testbed for innovation and often one of the first places where pharma companies launch their products. She also discusses how Sweden is…
Taiwan Yu-Ih Hou, mayor of New Taipei City, introduces the city and highlights its key competitive advantages and strategic direction of growth as Taiwan’s top economic and cultural destination. Over one-fourth of Taiwan’s biomedical industry is based in the greater Taipei community – most of which are small companies carrying…
Sweden Niels Abel Bonde, general manager of Novo Nordisk Sweden, explains the strategic significance of the Swedish market as an innovation-driven environment ideal to run pilot launches and real-world studies. He also breaks down the performance of the affiliate in its main therapeutic areas, as well as the positives and negatives…
Sweden The American Chamber of Commerce in Sweden promotes trade and investment between the USA and Sweden. Peter Dahlen, AmCham Sweden’s managing director, outlines the significance of Swedish American ties, both macroeconomically and from a healthcare investment standpoint. This is in addition to the success of American companies in the country…
Thailand PharmaBoardroom last reported on Thailand in 2015, meeting country managers from across the healthcare and life sciences value chain. Here, we chart some of their career progressions since then. Sticking with Servier Guillaume Drianno Guillaume Drianno was Thailand country manager for French firm Servier between 2013 and 2017. Prior…
Puerto Rico José F. Oramas, country manager of UPS Puerto Rico, highlights Puerto Rico’s position as a frontrunner in healthcare logistics innovation due to the island’s strong pharmaceutical manufacturing footprint. He emphasizes UPS’ commitment to the island providing tailor-made solutions to its clients in the industry. For UPS, Puerto Rico is…
Biotech With a strong research base formed around the Karolinska Institute and Uppsala University, Sweden has grown to be one of Europe’s premier biotech hotspots. Several companies spun out of research conducted at these institutes and others are now listed on the Stockholm stock exchange and already have products on the…
Sweden The top 50 most sold drugs in Sweden for 2018. AbbVie’s Humira takes the top spot for the second year running, followed by Gilead’s Epclusa and BMS and Pfizer’s Eliquis. Made with Visme Infographic Maker
Sweden Sweden’s top pharma export destinations. China is the largest single recipient of Swedish-made pharmaceuticals, followed by Germany and the USA. Made with Visme Infographic Maker The countries from which Sweden imports the most pharmaceuticals. Germany is top, followed by neighbouring Denmark, then the USA. Made with Visme Infographic Maker…
Taiwan Carol Cheng, chief operating officer of the Taiwan Research-based Biopharmaceutical Manufacturers Association (TRPMA), gives an update on the current condition of Taiwan’s biopharma environment and speaks about the country’s innovative capacity as an industry leader not only in the region but globally. In total, there are 295 Taiwan new…
See our Cookie Privacy Policy Here